
Michael Rendl, MD
About Me
Michael Rendl is a stem cell biologist studying the function of stem cell niches. A major focus of his work is to uncover how Dermal Papilla and Dermal Sheath cells act as specialized instructive niche cells for hair follicle stem cells during embryonic hair follicle formation and adult hair growth and regeneration.
For more detailed information, please visit the Rendl Lab website.
Language
English
Position
ASSOCIATE DIRECTOR, BLACK FAMILY STEM CELL INSTITUTE, PROFESSOR | Stem Cell Biology And Regenerative Medicine, PROFESSOR | Dermatology
Research Topics
Developmental Biology, Morphogenesis, Regeneration, Stem Cells
Multi-Disciplinary Training Areas
Development Regeneration and Stem Cells [DRS]
Education
MD, Medical University of Vienna
Postdoctoral Fellow, Rockefeller University
Awards
2014
Irma T. Hirschl Trust Research Award
2009
Research Career Development Award Dermatology Foundation
2002
Schrodinger Fellow of the Austrian Science Fund
2001
Max Kade Fellow of the Austrian Academy of Sciences
1999
AESCA Award for Dermatological Research
Research
Publications
Selected Publications
- Two’s Company, Three’s a Hair Cycle? hfDSCs Join the Hair Germ–Dermal Papilla Regulatory Interface. Adrian Kwiatkowski, Michael Rendl. Journal of Investigative Dermatology
- Molecular signatures and signaling interactions of the hair follicle stem cell niche. Sangeeta Ghuwalewala, Jenny Cao, Amelie Rezza, Martina Rangl, Adrian Kwiatkowski, Alexia Brown, Laura Grisanti, Nicholas Heitman, Markus Schober, Zichen Wang, Avi Ma’ayan, Axel A. Almet, Maksim V. Plikus, Michael Rendl. Journal of Investigative Dermatology
- Molecular and spatial landmarks of early mouse skin development. Tina Jacob, Karl Annusver, Paulo Czarnewski, Tim Dalessandri, Christina Kalk, Chiara Levra Levron, Nil Campamà Sanz, Maria Eleni Kastriti, Marja L. Mikkola, Michael Rendl, Beate M. Lichtenberger, Giacomo Donati, Åsa K. Björklund, Maria Kasper. Developmental Cell
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Rendl has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.